The first phase of our basic pipeline consists in isolating the strains from soil and plant tissues, followed by a genetic analysis for their correct identification.
In this step, all strains identified as opportunistic pathogens are eliminated from the pipeline.
We can also use a strain owned and provided by our client.
In the second phase, we perform tests to verify the strains ability in promoting plant-growth. Some of these abilities are related to their capacity of providing nutrients such as N and P and producing beneficial molecules such as phytohormones and antibiotics.
We also apply our innovative technology to verify which strains are compatible and can act in synergy when in consortium.
In the third phase, the strains/consortia are applied in specific crops, using different approaches. These approaches allow us to identify the treatments that promotes beneficial traits in normal conditions and tolerance in stressing conditions, such as drought, lack of nutrients, high salinity, among others.
First tests are performed in greenhouse, and the selected treatments are applied in field conditions.
All successful treatments identified in the third phase will undergo formulation tests in order to guarantee strains survival and stability in liquid, solid, emulsions or other formulation type.
The final formulation corresponds to the product prototype and can be scaled up and adjusted for large production.
The final phase consists in applying the product prototype in the fields for the agronomic efficacy validation.
We rely on certified research organizations to perform a complete and deep analysis of the product efficacy.
If succesful, the product is now ready to undergo registration process and commercialization.